Interestingly, PSMA-TLQ remained a significant prognosticator of overall survival, even if the regression was adjusted for the presence of visceral, bone, and lymph node metastases. The gene discussed is FOLH1; the disease is metastatic malignant neoplasm in the lymph nodes.